A pediatric fatality due to accidental hydromorphone ingestion

被引:4
作者
Cantrell, F. Lee [1 ]
Sherrard, James [2 ]
Andrade, Michael [2 ]
Schaber, Bethann [2 ]
Mclntyre, Iain M. [2 ]
机构
[1] Univ Calif San Francisco, San Diego Div, Calif Poison Control Syst, 200 W Arbor Dr, San Francisco, CA 92103 USA
[2] Cty San Diego Med Examiners Dept, San Diego, CA USA
关键词
Hydromorphone; pediatric; fatality; postmortem blood; liver; postmortem redistribution; AMERICAN ASSOCIATION; PAIN;
D O I
10.1080/15563650.2016.1247958
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background: Death due to prescription opioid exposure has increased dramatically in North America. Currently, there is a lack of literature detailing potentially lethal doses as well as postmortem tissue analysis concentrations from prescription opioid fatalities in children. We report a pediatric hydromorphone fatality with postmortem peripheral blood, central blood, liver, and gastric concentrations. Case report: A 3-year-old male was found unresponsive on a couch. Emergency services were contacted and responders found him pulseless, apneic, and asystolic. Resuscitative measures were unsuccessful and he was pronounced dead at a local hospital soon after arrival. Postmortem investigations revealed that two hydromorphone tablets (2 mg each) were missing. There was no demonstrable natural disease or traumatic injury to which to attribute his death upon autopsy; while postmortem concentrations of hydromorphone were confirmed and quantitated in peripheral blood at 0.03 mg/L, central blood 0.06 mg/L, and liver 0.10 mg/kg. Conclusion: Given the paucity of reported pediatric opioid-related fatalities, we describe a hydromorphonep-related death in a child, which includes postmortem hydromorphone concentrations.
引用
收藏
页码:60 / 62
页数:3
相关论文
共 15 条
[1]  
[Anonymous], 2009, DIL TABL PACK INS
[2]   2011 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report [J].
Bronstein, Alvin C. ;
Spyker, Daniel A. ;
Cantilena, Louis R., Jr. ;
Rumack, Barry H. ;
Dart, Richard C. .
CLINICAL TOXICOLOGY, 2012, 50 (10) :911-1164
[3]   2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report [J].
Bronstein, Alvin C. ;
Spyker, Daniel A. ;
Cantilena, Louis R. ;
Green, Jody L. ;
Rumack, Barry H. ;
Dart, Richard C. .
CLINICAL TOXICOLOGY, 2011, 49 (10) :910-941
[4]  
Bruera E, 1996, CANCER, V78, P852, DOI 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO
[5]  
2-T
[6]  
CDC, 2015, TABL 40 SPEC DRUGS I
[7]   Non-medical prescription opioid use, prescription opioid-related harms and public health in Canada: An update 5 years later [J].
Fischer, Benedikt ;
Gooch, Jenna ;
Goldman, Brian ;
Kurdyak, Paul ;
Rehm, Juergen .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2014, 105 (02) :E146-E149
[8]  
KOREN G, 1989, PEDIATR CLIN N AM, V36, P1141
[9]   Oxymorphone-Involved Fatalities: A Report of Two Cases [J].
McIntyre, Iain M. ;
Sherrard, James L. ;
Nelson, Craig L. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2009, 33 (09) :615-619
[10]   2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report [J].
Mowry, James B. ;
Spyker, Daniel A. ;
Brooks, Daniel E. ;
Mcmillan, Naya ;
Schauben, Jay L. .
CLINICAL TOXICOLOGY, 2015, 53 (10) :962-1146